caffeine has been researched along with MS (Multiple Sclerosis) in 11 studies
Excerpt | Relevance | Reference |
---|---|---|
"The association between alcohol and caffeine intakes and risk of multiple sclerosis (MS) is unclear; no prospective studies have examined this relationship." | 7.79 | Caffeine and alcohol intakes have no association with risk of multiple sclerosis. ( Ascherio, A; Massa, J; Munger, KL; O'Reilly, EJ, 2013) |
"Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener." | 5.32 | A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. ( Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW, 2004) |
"The association between alcohol and caffeine intakes and risk of multiple sclerosis (MS) is unclear; no prospective studies have examined this relationship." | 3.79 | Caffeine and alcohol intakes have no association with risk of multiple sclerosis. ( Ascherio, A; Massa, J; Munger, KL; O'Reilly, EJ, 2013) |
"Fluid intake and lower urinary tract symptoms were assessed by the questionnaire based voiding diary and the American Urological Association Symptom Score, respectively." | 1.56 | Fluid Intake and Urinary Symptoms in Patients with Multiple Sclerosis. ( Cheung, A; Gross, MD; Kim, JM; Melville, PM; Tam, J; Weissbart, SJ, 2020) |
"Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener." | 1.32 | A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. ( Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Sharma, K | 1 |
Fallon, SJ | 1 |
Davis, T | 1 |
Ankrett, S | 1 |
Munro, G | 1 |
Christopher, G | 1 |
Coulthard, E | 1 |
Herden, L | 1 |
Weissert, R | 1 |
Tam, J | 1 |
Gross, MD | 1 |
Cheung, A | 1 |
Melville, PM | 1 |
Kim, JM | 1 |
Weissbart, SJ | 1 |
Janitschke, D | 1 |
Lauer, AA | 1 |
Bachmann, CM | 1 |
Grimm, HS | 1 |
Hartmann, T | 1 |
Grimm, MOW | 1 |
Evans, E | 1 |
Piccio, L | 1 |
Cross, AH | 1 |
Chen, GQ | 1 |
Chen, YY | 1 |
Wang, XS | 1 |
Wu, SZ | 1 |
Yang, HM | 1 |
Xu, HQ | 1 |
He, JC | 1 |
Wang, XT | 1 |
Chen, JF | 1 |
Zheng, RY | 1 |
Massa, J | 1 |
O'Reilly, EJ | 1 |
Munger, KL | 1 |
Ascherio, A | 1 |
FINKE, H | 1 |
POPEK, K | 1 |
Tsutsui, S | 1 |
Schnermann, J | 1 |
Noorbakhsh, F | 1 |
Henry, S | 1 |
Yong, VW | 1 |
Winston, BW | 1 |
Warren, K | 1 |
Power, C | 1 |
Maas, AG | 1 |
Hogenhuis, LA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD:A Randomized, Double Blind, Placebo-controlled, Multicentric Trial.[NCT04284059] | Phase 4 | 504 participants (Anticipated) | Interventional | 2021-02-25 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for caffeine and MS (Multiple Sclerosis)
Article | Year |
---|---|
Methylxanthines and Neurodegenerative Diseases: An Update.
Topics: Alzheimer Disease; Animals; Caffeine; Coffee; Humans; Multiple Sclerosis; Neurodegenerative Diseases | 2021 |
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
Topics: Acetylcarnitine; Animals; Ascorbic Acid; Biotin; Caffeine; Creatine; Curcumin; Dietary Supplements; | 2018 |
9 other studies available for caffeine and MS (Multiple Sclerosis)
Article | Year |
---|---|
Preliminary evidence that caffeine improves attention in multiple sclerosis.
Topics: Attention; Attentional Blink; Caffeine; Cognition; Humans; Multiple Sclerosis; Reaction Time | 2022 |
The Effect of Coffee and Caffeine Consumption on Patients with Multiple Sclerosis-Related Fatigue.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Caffeine; Coffee; Disability Evaluation; Drinking Behavi | 2020 |
Fluid Intake and Urinary Symptoms in Patients with Multiple Sclerosis.
Topics: Adult; Beverages; Caffeine; Cross-Sectional Studies; Drinking; Female; Humans; Lower Urinary Tract S | 2020 |
Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Topics: Animals; Caffeine; Central Nervous System; Cytokines; Disease Models, Animal; Dose-Response Relation | 2010 |
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Topics: Alcohol Drinking; Caffeine; Diet; Female; Humans; Multiple Sclerosis; Risk Factors; Surveys and Ques | 2013 |
[The treatment of spastic paralysis with intratendonous impletol injections].
Topics: Caffeine; Drug Combinations; Humans; Injections; Multiple Sclerosis; Muscle Spasticity; Paralysis; P | 1954 |
THE STUDY OF CHANGES IN THE SO-CALLED SUCCESSIVE CONTRAST IN NEUROLOGY.
Topics: Afterimage; Amphetamine; Arteriosclerosis; Brain Concussion; Brain Injuries; Brain Neoplasms; Bromid | 1964 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progre | 2004 |
Multiple sclerosis and possible relationship to cocoa: a hypothesis.
Topics: Animals; Cacao; Caffeine; England; Food Hypersensitivity; Humans; Israel; Multiple Sclerosis; Norway | 1987 |